期刊文献+

局部晚期鼻咽癌300例放射化学治疗远期效果分析 被引量:4

Long-term effect of radiochemistry on 300 patients with local advanced nasopharyngeal carcinoma
下载PDF
导出
摘要 目的观察局部晚期鼻咽癌放射治疗联合诱导和(或)同步化学治疗的疗效和副反应,分析影响生存率和局部控制率的预后因素。方法共收集1995年1月至1998年12月在福建省肿瘤医院接受化学治疗联合放射治疗的Ⅲ~Ⅳa期初治鼻咽癌300例,其中诱导化学治疗94例(31.1%),同步化学治疗64例(21.3%),诱导化学治疗+同步化学治疗142例(47.3%)。所有患者均采用常规分割外照射,放射线采用^60Co伽玛线或6Mv-X线,原发灶中位剂量72Gy,23例患者外照射后补充后装治疗。化学治疗方案均采用5-氟尿嘧啶+顺铂。中位随访时间为79个月。主要随访观察指标:急性副反应、远期并发症、生存期、生存率、无远处转移生存率及局部控制率。结果早期反应主要为白细胞下降和口腔黏膜炎,严重晚期副反应主要为后组颅神经损伤。全组患者5a总生存率、原发灶控制率(局部控制率)、区域淋巴结控制率(区域控制率)和无远处转移生存率分别为67.7%、94.6%、94.3%和72.4%。单因素分析显示T分期、N分期、临床分期及化学治疗方式是影响生存的预后因素(P〈0.05)。多因素分析只有化学治疗方式是影响生存的独立预后因素(P〈0.05),诱导化学治疗加同步化学治疗患者的生存率和局部控制率均明显好于单纯诱导化学治疗和同步化学治疗者(P〈0.05)。但化疗方式并不影响远处转移率。结论放射治疗联合应用化学治疗对局部晚期鼻咽癌疗效理想,耐受性好。诱导加同步化学治疗疗效最好,但需要大规模前瞻性研究进一步证实。 Objective To evaluate the long-term effect and side effect of radio-chemotherapy in treatment of local advanced nasopharyngeal carcinoma, and to analyze the prognostic factors of survival and local control. Methods During the period of January 1995 to December 1998, 300 newly diagnosed, stage Ⅲ -Ⅳa nasopharyngeal carcinoma patients were treated with radiochemotherapy in Fujian Provincial Tumor Hospital. Among these patients, 94( 31.1% ) received induction chemotherapy, 64(21.3% ) received radiochemotherapy concomitantly and 142(47.3% ) received both induction and synchronal chemotherapy. All chemotherapy regimen was DDP plus 5-Fu. The median radiation dose was 72Gy to the GTV. Results The most early side effects were myelosuppression and mucositis, and the late side effects was Injury of cranial nerve. The 5-year overall survival, primary site control, regional node control and metastases free survival was 67.7%, 94.6% ,94.3% and 72.4% respectively. In univariate analysis, T stage, N stage, TNM stage and chemotherapy modality were significant factors for survival (P 〈 0.05 ). After the adjustment of multivariate analysis, only chemotherapy modality was an independent predictor both for survival( P 〈 0.05 ) and local control ( P 〈 0.05 ). Conclusion Combined radiotherapy and chemotherapy is an effective and well-tolerated treatment method for local advanced nasopharyngeal carcinoma. Induction chemotherapy plus radio-chemotherapy concurrently consult the best result and warrant more further investigation.
出处 《新乡医学院学报》 CAS 2008年第5期485-488,共4页 Journal of Xinxiang Medical University
关键词 鼻咽癌 放射疗法 化学疗法 预后 nasopharyngeal carcinoma radiotherapy chemotherapy prognosis
  • 相关文献

参考文献11

  • 1Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group(RTOG) and the european organization for research and treatment of cancer ( EORTC ) [ J ]. Int J Radiat Oncol Biol Phys,1995,31 (5) :1341-1346.
  • 2Chua DT, Sham JS, Choy D, et al. Preliminary report of the asian-o- ceanian clinical oncology association randomized trial comparing cisplatin and eprirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma [ J]. Cancer, 1998,83 ( 11 ) : 2270- 2283.
  • 3Huncharek M, Kupelnick B. Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials[ J]. Am J Clin Oncol,2002,25 ( 3 ) :219-223.
  • 4Al-Sarraf M, Le Blanc M, Girl PG, et aL Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase Ⅲ randomized intergroup study 0099[J]. J Clin Oncol, 1998,16(4) :1310-1317.
  • 5Oh J, Vokes E, Kies M, et al. Induction chemotherapy followed by concomitant chemoradiotherapy for advanced nasopharyngeal cancer[ J]. Ann Oncol,2002,14(4) :565-569.
  • 6Johnson FM,Palmer JL. Kies M,et al. A phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status[ J]. Cancer,2004, 100(5) :991-998.
  • 7Rischin D, Corry J, Smith J, et al. Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation [J ]. J Clin Oncol,2002,20(7 ) : 1845-1852.
  • 8Chua DT, Ma J, Sham J. Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma:a pooled data analysis Of two phase Ⅲ trialS [ J ]. J Clin Oncol ,2005,23 (6) : 1118-1124.
  • 9Hareyama M, Sakata K, Shirato H, et al. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma [ J ]. Cancer,2002:94( 8 ) :2217-2223.
  • 10蔡永广,符爱珍,劳逸.新辅助化疗联合放疗治疗中晚期鼻咽癌的疗效观察[J].现代肿瘤医学,2007,15(2):187-189. 被引量:7

二级参考文献12

  • 1李青兰,刘莲花.新辅助化疗加放疗治疗鼻咽癌疗效观察[J].肿瘤研究与临床,2004,16(4):281-282. 被引量:7
  • 2金风,文小平,吴庆芬,吴伟莉.HPF与PF方案联合放疗治疗鼻咽癌的临床研究[J].临床肿瘤学杂志,2004,9(5):464-465. 被引量:17
  • 3管忠震.鼻咽癌化学治疗的概况[J].癌症,1989,8(2):120-121. 被引量:66
  • 4谷铣之,殷蔚伯,刘泰福,等.肿癌放射治疗学[M].北京:北京医科大学中国协和医科大学联合出版社,1997,452.
  • 5Lin JC,Jan JS,Hsu CY,et al.Phase Ⅲ study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma:positive effect on overall and progression-free survival[J].J Clin Oncol,2003,21 (4):631.
  • 6秦风展,陈振东,樊青霞,等.肿瘤内科治疗学-新理论、新观点、新技术[M].北京:人民军医出版社,2004.452.
  • 7Khoury G,Paterson I.Nasopharyngeal carcinoma:A review of cases treated by radiotherapy and chemotherapy[J].Clin radiol,1987,38:17 ~ 19.
  • 8Cvitkovic E,Eschwege F,Rahal M,et al.Preliminary results of a randomized trial comparing neoadjuvant chemotherapy plus radiotherapy alone in stage Ⅳ (N2 M0) undifferentiated nasopharyngeal carcinoma[J].Int J Radiat Oncol Biol Phys,1996,35 (3):463 ~466.
  • 9Geara F,Glisson B,Sanguineti G,et al.Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma results of a matched cohort study[J].Cancer,1997,79:1279 ~ 1282.
  • 10闵华庆,郭翔.鼻咽癌研究回顾与展望[J].国外医学(肿瘤学分册),2000,27(1):11-14. 被引量:17

共引文献6

同被引文献32

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部